Alnylam Pharmaceuticals, Inc.

Global Retirement Partners, LLC ALNY

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/6/2026

Shares

1,856

Value ($000)

738

Weight

0.0%

2019 Q4 - 2025 Q4 (23 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/6/2026	738	0.0%	1,856	12/31/2025
2025 Q3	10/21/2025	205	0.0%	449	9/30/2025
2025 Q2	8/12/2025	49	0.0%	151	6/30/2025
2024 Q4	1/31/2025	19	0.0%	81	12/31/2024
2024 Q3	10/16/2024	28	0.0%	101	9/30/2024
2024 Q2	7/23/2024	13	0.0%	53	6/30/2024
2024 Q1	4/23/2024	9	0.0%	63	3/31/2024
2023 Q4	1/18/2024	15	0.0%	78	12/31/2023
2023 Q3	10/13/2023	15	0.0%	90	9/30/2023
2023 Q2	7/20/2023	16	0.0%	85	6/30/2023
2023 Q1	5/8/2023	17	0.0%	85	3/31/2023
2022 Q4	2/13/2023	18	0.0%	77	12/31/2022
2022 Q3	11/3/2022	17	0.0%	81	9/30/2022
2022 Q2	7/15/2022	767	0.1%	5,260	6/30/2022
2022 Q1	7/14/2022	662	0.1%	5,213	3/31/2022
2021 Q3	10/22/2021	384	0.0%	2,034	9/30/2021
2021 Q2	7/15/2021	334	0.0%	1,972	6/30/2021
2021 Q1	4/14/2021	256	0.0%	1,812	3/31/2021
2020 Q4	1/13/2021	11	0.0%	84	12/31/2020
2020 Q3	10/9/2020	12	0.0%	84	9/30/2020
2020 Q2	7/13/2020	12	0.0%	84	6/30/2020
2020 Q1	4/28/2020	9	0.0%	80	3/31/2020
2019 Q4	1/23/2020	9	0.0%	80	12/31/2019